Tennessee House Bill HB1310

Tennessee 2023-2024 Regular Session

• Introduced: 1/31/23
• Refer: 2/2/23
• Refer: 3/21/23
• Refer: 3/28/23
• Engrossed: 4/6/23
• Enrolled: 4/11/23
• Passed: 4/28/23
• Chaptered: 5/3/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 47, relative to genetic information.

Impact

If implemented, AB 1310 will significantly influence how genetic data is managed in Tennessee. It establishes strict guidelines that these companies must adhere to, including the necessity for valid legal processes when disclosing genetic data to law enforcement and the obligation to maintain comprehensive security measures to protect consumer data. The Act is expected to foster consumer trust in genetic testing services by ensuring their sensitive information is managed responsibly and with respect. The enforcement of these provisions rests with the division of consumer affairs in the Office of the Attorney General.

Summary

House Bill 1310, also known as the Genetic Information Privacy Act, amends the Tennessee Code Annotated to enhance the privacy protections surrounding genetic information. The bill imposes requirements on direct-to-consumer genetic testing companies, mandating them to obtain express written consent from consumers before collecting, using, or disclosing their genetic data. The legislation aims to increase transparency in how genetic information is handled, ensuring consumers are informed about their rights and the company’s practices regarding their data.

Sentiment

The general sentiment surrounding HB 1310 is largely positive, with a consensus among advocates stressing the importance of consumer privacy in the rapidly evolving field of genetic testing. Proponents argue that the enhanced privacy measures are essential in protecting consumers from potential misuse of genetic information. However, concerns were voiced about the potential burdens this legislation might place on businesses in terms of compliance and the implementation of new privacy practices, signaling a cautious optimism among industry stakeholders.

Contention

Discussions around HB 1310 highlighted potential points of contention regarding the balance between consumer privacy and the operational capabilities of genetic testing companies. Some critics expressed worries that the stringent consent requirements might hinder access to genetic testing services and slow the pace of innovation in the industry. Furthermore, there were debates regarding how these regulations might interact with existing federal laws governing health information, which some stakeholders feared could lead to confusion in compliance.